We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.48%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$76.3B
AUM Growth
+$3.71B
(+5.1%)
Cap. Flow
-$8.32B
Cap. Flow
% of AUM
-10.91%
Top 10 Holdings %
Top 10 Hldgs %
21.64%
Holding
2,644
New
223
Increased
746
Reduced
756
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$315M |
| 2 |
UnitedHealth
UNH
|
+$251M |
| 3 |
Union Pacific
UNP
|
+$248M |
| 4 |
Chevron
CVX
|
+$165M |
| 5 |
CYBR
CyberArk
CYBR
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$252M |
| 2 |
Aon
AON
|
+$184M |
| 3 |
Meta Platforms (Facebook)
META
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$156M |
| 5 |
PayPal
PYPL
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.85% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.91% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Neogen
NEOG
$2.5B
| $2.59M | ﹤0.01% |
139,927
+1,644
| +1% | +$30.9K |
|
|
HQL
652
abrdn Life Sciences Investors
HQL
$627M
| $2.58M | ﹤0.01% |
185,332
| – | – |
|
653
Coherus Oncology
CHRS
$196M
| $2.58M | ﹤0.01% |
377,333
+59,611
| +19% | +$463K |
|
654
FedEx
FDX
$75.4B
| $2.55M | ﹤0.01% |
11,176
+2,499
| +29% | +$507K |
|
655
Moderna
MRNA
$23.6B
| $2.55M | ﹤0.01% |
16,593
+510
| +3% | +$84.1K |
|
656
EOG Resources
EOG
$70.7B
| $2.5M | ﹤0.01% |
21,829
+28
| +0.1% | +$3.4K |
|
657
Ross Stores
ROST
$81.9B
| $2.5M | ﹤0.01% |
23,563
+22,416
| +1,954% | +$2.52M |
|
658
BlackRock Health Sciences Trust II
BMEZ
$998M
| $2.41M | ﹤0.01% |
144,466
-20
| -0% | -$322 |
|
|
PINC
659
DELISTED
Premier
PINC
| $2.41M | ﹤0.01% |
74,587
-2,018
| -3% | -$66.1K |
|
660
iShares US Treasury Bond ETF
GOVT
$43.6B
| – | – |
0
| – | – |
|
661
Lufax Holding
LU
$1.3B
| $2.4M | ﹤0.01% |
+293,973
| New | +$2.82M |
|
662
Insulet
PODD
$9.79B
| $2.39M | ﹤0.01% |
7,493
-346
| -4% | -$103K |
|
663
Jack Henry & Associates
JKHY
$11.1B
| $2.39M | ﹤0.01% |
15,845
-356
| -2% | -$59.4K |
|
|
CDMO
664
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.38M | ﹤0.01% |
127,008
-77,656
| -38% | -$1.28M |
|
665
J.M. Smucker
SJM
$12.8B
| $2.37M | ﹤0.01% |
15,072
-799
| -5% | -$121K |
|
|
TGNA
666
DELISTED
TEGNA Inc
TGNA
| $2.37M | ﹤0.01% |
+140,226
| New | +$2.62M |
|
667
FirstEnergy
FE
$27.5B
| $2.37M | ﹤0.01% |
59,154
-62,536
| -51% | -$2.53M |
|
|
GTM
668
ZoomInfo Technologies
GTM
$1.22B
| $2.36M | ﹤0.01% |
95,696
+50,392
| +111% | +$1.29M |
|
669
SLB Ltd
SLB
$75B
| $2.36M | ﹤0.01% |
48,051
+670
| +1% | +$35.6K |
|
670
Emcor
EME
$36B
| $2.34M | ﹤0.01% |
14,381
-59,890
| -81% | -$9.21M |
|
|
APLS
671
DELISTED
Apellis Pharmaceuticals
APLS
| $2.33M | ﹤0.01% |
35,304
-49,516
| -58% | -$2.86M |
|
672
Regency Centers
REG
$14.1B
| $2.33M | ﹤0.01% |
38,058
+31,655
| +494% | +$1.99M |
|
673
MaxCyte
MXCT
$126M
| $2.31M | ﹤0.01% |
467,130
+110,069
| +31% | +$542K |
|
674
Recursion Pharmaceuticals
RXRX
$1.72B
| $2.3M | ﹤0.01% |
345,540
+181,631
| +111% | +$1.44M |
|
|
MAXN
675
DELISTED
Maxeon Solar Technologies
MAXN
| $2.29M | ﹤0.01% |
864
-3,089
| -78% | -$6.58M |
|
Similar funds
QCM
Lazard Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Lazard Asset Management held 2,644 positions worth $76.3B, up 5.1% from $72.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management withdrew a net $8.32B in Q1 2023, closing 309 positions and reducing 756 holdings. Its most notable exit was Linde, an estimated $56.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Fomento Económico Mexicano worth $11.2M.
- Lazard Asset Management's largest Q1 2023 buy was Fomento Económico Mexicano: 117,338 shares worth $11.2M.
- Lazard Asset Management added most to Norfolk Southern in Q1 2023, an estimated $315M increase.
- Lazard Asset Management's biggest Q1 2023 reduction was Analog Devices, cutting an estimated $252M.
- Lazard Asset Management fully exited Linde in Q1 2023, selling an estimated $56.6M.
- Lazard Asset Management's ten largest holdings make up 22% of its $76.3B portfolio in Q1 2023.
- Lazard Asset Management opened 223 new positions and closed 309 in Q1 2023.
- Lazard Asset Management's portfolio value rose 5.1% quarter-over-quarter to $76.3B.
Based on Lazard Asset Management's 13F filing for Q1 2023, filed 15 May 2023.